Table 1 Characteristics of participants and vaccination status
LJEV group | IJEV-IJEV with 7 days interval group | IJEV-IJEV with 28 days interval group | Control group | |
|---|---|---|---|---|
N | 161 | 158 | 152 | 157 |
Age (years) | ||||
mean ± SD | 55.00 ± 8.63 | 54.37 ± 9.33 | 54.82 ± 8.10 | 54.29 ± 9.56 |
Age groups (years) | ||||
40–49 [n (%)] | 51 (31.68) | 51 (32.28) | 49 (32.24) | 53 (33.76) |
50–59 [n (%)] | 55 (34.16) | 53 (33.54) | 52 (34.21) | 52 (33.12) |
60–69 [n (%)] | 55 (34.16) | 54 (34.18) | 51 (33.55) | 52 (33.12) |
Gender | ||||
Male [n (%)] | 56 (34.78) | 56 (35.44) | 68 (44.74) | 49 (31.21) |
Female [n (%)] | 105 (65.22) | 102 (64.56) | 84 (55.26) | 108 (68.79) |
Interval between doses (days) | ||||
median (min, max) | 0 (0, 0) | 8 (7, 8) | 29 (8, 30) | 0 (0, 0) |
Days from the first dose to the first blood sample | ||||
median (min, max) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) | 0 (0, 0) |
Days from the first dose to the second blood sample | ||||
median (min, max) | 8 (8, 8) | 8 (8, 8) | 29 (8, 30) | 21 (21, 21) |
Days from the last dose to the third blood sample | ||||
median (min, max) | 29 (29, 29) | 29 (21, 30) | 29 (28, 29) | 29 (29, 29) |
Days from the last dose to the fourth blood sample | ||||
median (min, max) | 510 (510, 519) | 502 (502, 511) | 481 (480, 503) | 482 (481, 492) |
